Oxford Gene Technology (OGT), provider of innovative clinical genetics and
diagnostic solutions to advance molecular medicine, recently
announced details of its new targeted sequencing service as part of a workshop
at the European Society of Human Genetics Conference (ESHG 2011) in Amsterdam,
The Netherlands. The workshop, entitled "
Adding value
through analysis", attracted
over 130 delegates and featured presentations from OGT team members discussing
the key elements of the service. Built on a strong foundation of
flexibility, expert project design and advanced data reporting, the new offering
is focused on providing researchers with clear, prioritised results that are
optimised for quick and insightful interpretation. This is achieved by utilising OGT's internationally recognised
probe design and data analysis expertise combined with their independently
accredited laboratory processes.
Dr
Mike Evans, OGT's CEO and one of the presenters at the meeting, commented: "We
were pleased to see such significant interest in OGT's new targeted sequencing
service. At OGT, we always seek to understand the biological question
underlying each experiment and are aware of the data challenges facing the
widespread use of next generation technologies. As such, rather than generating
complex, insurmountable data sets, our service is specifically designed to deliver
meaningful, filtered results."
As
part of the service, researchers can perform whole exome or custom analyses
using novel capture probes designed by OGT experts that achieve highly
efficient and uniformly distributed target capture. This expands the options
available, all of which can be combined seamlessly
with other aspects of OGT's
GenefficiencyTM
Genomic Services to provide the
complete solution for genomic research.
To see the presentations from the OGT Workshop
and to find out more about Genefficiency Genomic Services, visit
www.ogt.co.uk/ESHG2011.
